Dipeptidyl peptidase IV inhibitors in diabetes: more than inhibition of glucagon-like peptide-1 metabolism?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00210-008-0280-0
Reference23 articles.
1. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, Bloom SR (2002) Gut hormone PYY3–36 physiologically inhibits food intake. Nature 418:650–654
2. Bischoff A, Michel MC (1998) Neuropeptide Y lowers blood glucose in anaesthetized rats via a Y5 receptor subtype. Endocrinol 139:3018–3021
3. Boggiano MM, Chandler PC, Oswald KD, Rodgers RJ, Blundell JE, Ishii Y, Beattie AH, Holch P, Allison DB, Schindler M, Arndt K, Rudolf K, Mark M, Schoelch C, Joost HG, Klaus S, Thöne-Reineke C, Benoit SC, Seeley RJ, Beck-Sickinger AG, Koglin N, Raun K, Madsen K, Wulff BS, Stidsen CE, Birringer M, Kreuzer OJ, Deng XY, Whitcomb DC, Halem H, Tayloer J, Dong J, Datta R, Culler M, Ortmann S, Castaneda TR, Tschöp M (2005) PYY3–36 as an anti-obesity drug target. Obesity Rev 6:307–322
4. Boonacker E, Van Noorden CJF (2003) The multifunctional or moonlighting protein CD26/DPPIV. Eur J Cell Biol 82:53–73
5. Combettes M, Kargar C (2008) Newly approved and promising antidiabetic agents. Therapie 62:293–310
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Neuropeptide Y Peptide Family and Cancer: Antitumor Therapeutic Strategies;International Journal of Molecular Sciences;2023-06-09
2. Gut Molecules in Cardiometabolic Diseases: The Mechanisms behind the Story;International Journal of Molecular Sciences;2023-02-08
3. Pharmacology of Gut Hormone Mimetics for Obesity and Diabetes;Reference Module in Biomedical Sciences;2021
4. Established and emerging roles peptide YY (PYY) and exploitation in obesity–diabetes;Current Opinion in Endocrinology, Diabetes & Obesity;2020-12-30
5. Generation and characterisation of C-terminally stabilised PYY molecules with potential in vivo NPYR2 activity;Metabolism;2020-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3